HIGHLIGHTS
- who: Theresa Guo from the University Health Network, Canada have published the research: Current perspectives on recurrent HPV-mediated oropharyngeal cancer, in the Journal: (JOURNAL)
SUMMARY
Despite the improved prognosis conferred by human papillomavirus (HPV)-positive tumor status, recurrences and distant failures still occur in this population with progression free survival of 72-74% at 3-years. Recurrences tend to occur later in HPV-positive patients, but regardless of HPV-tumor status a majority of recurrences occur within 2 years of primary treatment. Distant recurrences do occur later in HPV-positive OPSCC, though . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.